Breast Cancer, Cancer Distress
Conditions
Keywords
Cancer-related Distress, Breast Cancer, Young Adult Cancer
Brief summary
This study aims to evaluate the use of mobile technology as a communication tool among patients with breast cancer and measured its effect on patient-reported cancer-related distress, specifically focusing on young women as they often face unique challenges.
Detailed description
This is a prospective, randomized, two stage study. The target population is adult females ≥ 18 and ≤ 45 years of age with breast cancer with a National Comprehensive Cancer Network (NCCN) Distress Thermometer score of distress score ≥ 4. The study will be conducted at Atrium Health Wake Forest Baptist Comprehensive Cancer Center (AHWFBCCC). The hypothesis is that the social connectivity via the Mighty Pro Application, as well as the educational components available in the application, will decrease patients' cancer-related distress. This study aims to evaluate the feasibility of implementing the Mighty Pro Application and measure its efficacy at reducing distress among young women with breast cancer.
Interventions
OTHERMighty Pro Application
Access to Mighty Pro Application
Sponsors
Wake Forest University Health Sciences
Atrium Health Levine Cancer Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
* Ability to understand and willingness to sign an IRB-approved informed consent * Age ≥ 18 and ≤ 45 years at the time of consent * Female * Established patient at Atrium Health Wake Forest Baptist Comprehensive Cancer Center (AHWFBCCC) * Histological confirmation of any type and stage (0-IV) of breast cancer * Screening (baseline) NCCN Distress Thermometer score ≥ 4 * Access to a mobile device for trial purposes and an active email address * Ability to read and understand the English language. NOTE: The Mighty Pro Application is available in English only. * As determined by the enrolling Investigator, ability of the participant to understand and comply with study procedures for the entire length of the study
Exclusion criteria
\- None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Stage 1: Feasibility of Implementation of Mighty Pro App | 26 Weeks | Binary variable indicating if at least one encounter with the application occurred for at least 80% of the weeks during the observation period. At the Participant level, the scale is either 0 (less than 80% utilization of the Mighty Pro App at least once per week during the 26-week observation period) or 1 (80% or greater utilization of the Mighty Pro App App at least once per week during the the 26-week observation period). |
| Stage 2: Efficacy of the Mighty Pro App | 26 Weeks | Binary variable indicating if at least a 2-point improvement was achieved from baseline to 26 weeks. At the Participant level, the scale is either 0 (the study participant did not achieve at least a 2-point improvement from baseline to 26 weeks on the distress scale) or 1 (the study participant did achieve at least a 2-point improvement from baseline to 26 weeks on the distress scale). The distress scale ranges from 0 (no distress) to 10 (extreme distress). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Efficacy of the Mighty Pro App in Improving Distress Scores | 52 Weeks | Binary variable indicating if at least a 2-point improvement was achieved from baseline to 52 weeks. At the Participant level, the scale is either 0 (the study participant did not achieve at least a 2-point improvement from baseline to 52 weeks on the distress scale) or 1 (the study participant did achieve at least a 2-point improvement from baseline to 52 weeks on the distress scale). The distress scale ranges from 0 (no distress) to 10 (extreme distress). |
| Efficacy of the Mighty Pro App in Improving Distress Scores - Quantitative | 52 Weeks | Quantitative distress scores collected for each participant and for each time point. For each Participant and each time point a quantitative measure will be collected ranging from 0 (no distress) to 10 (extreme distress). |
Countries
United States
Contacts
CONTACTMaggie Dzhanumova
PRINCIPAL_INVESTIGATORJulie Fisher, MD
Wake Forest University Health Sciences
Outcome results
None listed